Ad
related to: biogen's biib
Search results
RBC maintains $317 price target on Biogen stock, cites Skyclarys importance By Investing.com
Investing.com· 1 hour agoOn Wednesday, RBC (TSX:RY) Capital maintained its Outperform rating on Biogen (NASDAQ:BIIB) shares...
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance· 1 day agoIt is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock...
Biogen maintains stock target with Buy rating on acquisition intention By Investing.com
Investing.com· 7 days agoOn Wednesday, Biogen Inc (NASDAQ:BIIB) received confirmation from Stifel that its Buy rating and...
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
WJTV Jackson· 5 days ago("Biogen Inc." or "the Company") (NASDAQ: BIIB) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal ...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 6 days agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 days agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 11 hours ago(“Biogen” or the “Company”) (NASDAQ: BIIB) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise ...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 6 days agoThe acquisition will add Human Immunology Biosciences’ lead candidate, felzartamab, to Biogen’s...
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 1 day agoJust days after Biogen Inc. announced it was buying Human Immunology Biosciences (HI-Bio) for $1.15...
Biogen to acquire HI-Bio for up to $1.8 billion By Investing.com
Investing.com· 7 days agoBiogen Inc. (NASDAQ:BIIB) has reached a definitive agreement to acquire Human Immunology Biosciences...